Zimmer Biomet Holdings ZBH Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$295.4M-26.5% | -$292.8M-34.3% | -$282.8M-37.0% | -$261.7M-28.8% | -$233.5M-14.6% | ||
| $8.41B+9.2% | $8.23B+7.2% | $8.01B+5.5% | $7.83B+4.1% | $7.7B+3.3% | ||
| $2.52B+13.1% | $2.49B+13.8% | $2.29B+6.8% | $2.27B+6.8% | $2.23B+6.4% | ||
| $5.89B+7.7% | $5.74B+4.6% | $5.72B+5.0% | $5.57B+3.1% | $5.47B+2.1% | ||
| 70%-1.0pp | 69.7%-1.8pp | 71.4%-0.3pp | 71.1%-0.7pp | 71.1%-0.8pp | ||
| $451.3M+2.5% | $458.5M+4.8% | $448.3M+1.4% | $444M-0.8% | $440.1M-3.5% | ||
| $3.35B+13.4% | $3.26B+11.2% | $3.13B+7.8% | $3.03B+5.6% | $2.95B+3.3% | ||
| $676.9M+12.7% | $665.8M+12.5% | $645.7M+11.5% | $617.4M+7.2% | $600.8M+5.4% | ||
| $7.23B+13.2% | $7.13B+11.6% | $6.68B+5.3% | $6.57B+4.6% | $6.39B+2.4% | ||
| $1.18B-10.1% | $1.1B-14.6% | $1.33B+6.5% | $1.26B+1.8% | $1.31B+7.9% | ||
| 14%-3.0pp | 13.3%-3.4pp | 16.6%+0.2pp | 16.1%-0.4pp | 17%+0.7pp | ||
| $19.6M+170% | $25.5M+182% | -$28M-122% | -$26.2M-88.5% | -$28.1M-64.3% | ||
| $903.1M-14.0% | $830.8M-19.9% | $1.02B-1.0% | $972.9M-4.7% | $1.05B+5.5% | ||
| —— | —— | $214.6M— | $147.7M— | $135.6M— | ||
| $3.86-14.4% | $3.55-20.0% | $4.03-23.2% | $4.10-14.4% | $4.51-2.2% | ||
| $3.87-14.6% | $3.57-19.8% | $4.06-23.0% | $4.12-14.5% | $4.53-2.4% | ||
| 791.6M-2.6% | 795.5M-2.9% | 800.7M-3.0% | 804.9M-3.3% | 813M-2.7% | ||
| 789M-2.6% | 792.9M-2.9% | 798M-2.9% | 802.2M-3.2% | 810M-2.6% | ||
| $82M+142% | $77M+225% | $68.8M+350% | $107.6M+491% | $33.9M+62.2% | ||
| $676.9M+12.7% | $665.8M+12.5% | $645.7M+11.5% | $617.4M+7.2% | $600.8M+5.4% | ||
| -$295.4M-26.5% | -$292.8M-34.3% | -$282.8M-37.0% | -$261.7M-28.8% | -$233.5M-14.6% | ||
| $19.6M+170% | $25.5M+182% | -$28M-122% | -$26.2M-88.5% | -$28.1M-64.3% | ||
| $451.3M+2.5% | $458.5M+4.8% | $448.3M+1.4% | $444M-0.8% | $440.1M-3.5% | ||
| $151.5M+16.0% | $181.2M-17.3% | $95.8M-63.1% | $106.6M-57.6% | $130.6M-44.3% | ||
| $8.41B+9.2% | $8.23B+7.2% | $8.01B+5.5% | $7.83B+4.1% | $7.7B+3.3% | ||
| $1.18B-10.1% | $1.1B-14.6% | $1.33B+6.5% | $1.26B+1.8% | $1.31B+7.9% | ||
| $2.29B-1.5% | $2.19B-3.9% | $2.41B+8.1% | $2.3B+4.5% | $2.32B+6.9% | ||
| $2.29B-1.5% | $2.19B-3.9% | $2.41B+8.1% | $2.3B+4.5% | $2.32B+6.9% | ||
| 27.2%-3.0pp | 26.6%-3.1pp | 30%+0.7pp | 29.4%+0.1pp | 30.2%+1.0pp | ||
| $1.18B-10.1% | $1.1B-14.6% | $1.33B+6.5% | $1.26B+1.8% | $1.31B+7.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Zimmer Biomet Holdings's revenue?
- Zimmer Biomet Holdings (ZBH) generated $8.4B in revenue over the trailing twelve months, up 9.2% year over year.
- Is Zimmer Biomet Holdings profitable?
- Zimmer Biomet Holdings reported $761.1M in net income over the trailing twelve months, a 9.1% net margin.
- What are Zimmer Biomet Holdings's profit margins?
- Gross margin is 70.0% and operating margin is 14.0%, with a 9.1% net margin.
- What is Zimmer Biomet Holdings's earnings per share?
- Zimmer Biomet Holdings's diluted EPS over the trailing twelve months is $3.86.
- Where does Zimmer Biomet Holdings's income statement data come from?
- Every line is extracted from Zimmer Biomet Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
